| Authors: |
Cathcart-Rake EJ; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Thao V; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN.; OptumLabs, Eden Prairie, MN., Le-Rademacher J; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN., Helfinstine DA; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN., Ruddy KJ; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Vachon C; Division of Epidemiology, Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Davidge-Pitts C; Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN., Carroll E; Department of Radiology, Mayo Clinic, Rochester, MN., Scout N; National LGBT Cancer Network, Providence, RI., Ridgeway JL; Division of Health Care Delivery Research, Mayo Clinic, Rochester, MN., Shufelt CL; Division General Internal Medicine, Mayo Clinic, Jacksonville, FL.; Mayo Clinic Women's Health, Rochester, MN., Tevaarwerk A; Department of Medical Oncology, Mayo Clinic, Rochester, MN., Jatoi A; Department of Medical Oncology, Mayo Clinic, Rochester, MN. |
